Navigation Links
New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia

ession, and depression. Efficacy was assessed from the change from baseline to study endpoint (Day 42) using PANSS total score as well as positive symptom, negative symptom, general psychopathology, aggression, and depression rating scores.(2)

At Day 42, there were statistically significant reductions versus placebo with all doses of SEROQUEL XR for the change in PANSS total, positive subscale, general psychopathology subscale, and hostility and aggression scores. Changes in negative symptom and depression scores of the PANSS were statistically significant versus placebo for SEROQUEL XR 600 mg/day and 800 mg/day.(2)

IMPORTANT SAFETY INFORMATION FOR SEROQUEL XR

SEROQUEL XR is indicated for the treatment of schizophrenia. Patients should be periodically reassessed to determine the need for treatment beyond the acute response.

Elderly patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk (1.6 to 1.7 times) of death compared to placebo (4.5% vs 2.6%, respectively). SEROQUEL XR is not approved for the treatment of patients with dementia-related psychosis. (See Boxed Warning.)

Hyperglycemia, in some cases extreme and associated with ketoacidosis, hyperosmolar coma, or death, has been reported in patients treated with atypical antipsychotics, including quetiapine. The relationship of atypical use and glucose abnormalities is complicated by the possibility of increased risk of diabetes in the schizophrenic population and the increasing incidence of diabetes in the general population. However, epidemiological studies suggest an increased risk of treatment-emergent, hyperglycemia-related adverse events in patients treated with atypical antipsychotics. Patients starting treatment with atypical antipsychotics who have or are at risk for diabetes should undergo fasting blood glucose testing at the beginning of and during treatment. Patients who develop symptoms of hyperglycemia should also u
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:5/23/2013)... 23, 2013  PAREXEL International Corporation (NASDAQ: ... at the Jefferies Healthcare Conference in New York.  ... Chief Financial Officer, will be making a presentation on ... Monday, June 3, 2013. A live webcast ... section of PAREXEL,s website at www.PAREXEL.com in ...
(Date:5/22/2013)... , May 22, 2013  Aribex, Inc., manufacturer of ... today introduced a new color option, black with gray ... dental and veterinary markets. The popular white with light ... will continue to be available and both models can ... (Photo: http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental ...
(Date:5/22/2013)... NEW YORK , May 22, 2013 /PRNewswire/ ... is investigating potential claims on behalf of purchasers ... or the "Company") (NasdaqGS: AMAG -News).  The investigation ... violated federal securities laws. On May ... 10.73% during intraday trading after the company announced ...
Breaking Medicine Technology:PAREXEL International To Present At Jefferies Healthcare Conference 2Aribex Unveils New Color of NOMAD Pro 2 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2
... AUSTIN, Texas, June 29, 2011 Ascension Orthopedics, Inc., the ... the PyroTITAN™ Humeral Resurfacing Implant in Geelong, Australia by Richard ... "The patient was a 57-year-old, active male with ... by a fall from a mountain bike and not improved ...
... 2011 Medicines can cure disease, relieve symptoms, and ... a lot of damage if taken incorrectly, when not ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Studies estimate that up ... be prevented. Learn how FDA—through its Safe ...
Cached Medicine Technology:Ascension Orthopedics Implants PyroTITAN™ in Geelong, Australia 2
(Date:5/23/2013)... Francisco (PRWEB) May 23, 2013 Pyramid ... and tumor registry services at the National Cancer ... June 2 at the Hilton Union Square in San ... issues to help cancer registrars keep up-to-date with changes ... offers cancer registry executives numerous opportunities to gain perspectives ...
(Date:5/23/2013)... Ann Arbor, Mich. (PRWEB) May 23, 2013 ... the Ann Arbor creative firm was awarded a Silver ... category of Government Video. The winning entry was for ... was previously awarded “Best of Show” in the 2013 ... Flint metro regions. , The Summit Creative Award recognizes ...
(Date:5/23/2013)... Platinum Supplemental Insurance recently promoted ... Satterlee started her Platinum sales career in 2011. Her ... team of sales representatives selling Platinum products. , Platinum ... residents of rural communities. Satterlee is in charge of ... is help farmers prepare for the future in the ...
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 Fresh ... provide vending machines stocked with healthy food and drinks ... country. The company’s in-house, full-service marketing and advertising department ... possible in the media for their franchisees, and to ... Vending has been featured in many leading publications and ...
(Date:5/23/2013)... DC (PRWEB) May 23, 2013 Teen birth ... 2011, according to new data released today by ... time, the teen birth rate dropped at least 15% in ... , There were also dramatic declines among all racial/ethnic ... ,     Birth rates declined 40% or more for Hispanic ...
Breaking Medicine News(10 mins):Health News:Pyramid Healthcare Solutions to Spotlight Its Cancer Registry Services at 2013 NCRA Conference 2Health News:Pyramid Healthcare Solutions to Spotlight Its Cancer Registry Services at 2013 NCRA Conference 3Health News:Platinum Supplemental Insurance Promotes Mary Satterlee to Sales Team Leader 2Health News:Fresh Healthy Vending Receives Recent National and Local Media Focus 2
... wise not to drink the water. , Researchers from ... if their local water or air is contaminated with dangerous ... Andrew McKay, a PhD student at CRC CARE and The ... in a unique water microbe when it is exposed to ...
... Aug. 29, 2007 Michael Yarborough, a 58-year-old business ... three years ago revealed prostate cancer, but a side ... , After surgery to remove the cancer, I started ... company. Although my case was far better than most, ...
... Alcoholism a common trigger for downward social mobility, study ... alcoholism and living in a downscale neighborhood often go ... problem drinking that usually comes first. , "The more ... is going to remain in, or migrate into, a ...
... study finds , , TUESDAY, Aug. 28 (HealthDay News) -- Instead ... surgery -- both during and after the procedure. , According ... cancer surgery needed less anesthesia during the procedure, reported less ... had reduced costs. , "This helps women at a ...
... to describe the prevalence of HIV and Hepatitis B ... University of California, San Diego (UCSD) School of Medicine ... high-risk behavior could lead to an HIV epidemic in ... to reduce high-risk behaviors among injection drug users are ...
... researchers say , , TUESDAY, Aug. 28 (HealthDay News) -- ... sclerosis patients may help predict the severity of disease ... , "This is a new way to try to ... patient,s lesions," said lead researcher Dr. Rohit Bakshi, associate ...
Cached Medicine News:Health News:Biosensors to probe the metals menace 2Health News:New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence 2Health News:Drinking Often Spurs Move to Poorer Neighborhoods 2Health News:Drinking Often Spurs Move to Poorer Neighborhoods 3Health News:Hypnosis Eases Pain of Breast Cancer Surgery 2Health News:Hypnosis Eases Pain of Breast Cancer Surgery 3Health News:High-risk behaviors could lead to HIV epidemic in Afghanistan 2Health News:High-risk behaviors could lead to HIV epidemic in Afghanistan 3Health News:Brain Lesions Predict MS Progression 2Health News:Brain Lesions Predict MS Progression 3
... be used as a manual cell washer, as ... AHG spins, or as a vacutainer style blood ... washing rotor: easy to see pellets, securely holds ... for vacutainers, glove friendly membrane panels, cover interlock ...
... The Centra W Automatic Cell Washer does ... even does the final AHG spin. 80-second wash ... & spin functions (up to 999 sec) for ... x 75 tubes, audible end of run signal, ...
Excellent all-around performance in digital format - MIC-D offers an exciting new way to observe the natural world. Multiple performance features provide new ways to enjoy microscope observation....
... Coolscope operates with a simple click ... display. Direct the mouse cursor to ... image of the slide and the ... intuitive Graphic User Interface (GUI) enables ...
Medicine Products: